The phenytoin testing market is likely to record a strong CAGR of1.4 % during the forecast period. The phenytoin testing market is currently valued at US$ 6.6 Bn in 2022 and is likely to reach US$ 7.58 Bn by 2032.
| Report Attribute | Details |
| Estimated Base Year Value (2022) | US$ 6.6 Bn |
| Anticipated Forecast Value (2032) | US$ 7.58 Bn |
| Projected Growth Rate (2022-2032) | 1.4% CAGR |
Sales of phenytoin testing have risen owing to higher level of pathological significance of the test for healthcare professionals and patients.
Increased toxicity check is also projected to contribute to the growth of the phenytoin testing market share.
The report sheds light on the factors improving the sales of phenytoin testing, and, in turn, the opportunities for market players. However, the phenytoin testing market also faces some challenges, which might limit the phenytoin testing market share from reaching its potential.
Some of the key phenytoin testing market trends promoting the demand for phenytoin testing include higher consumption of phenytoin which is directly related to increasing incidence of drug toxicity and safe drug dose management.
The prominent factor propelling the growth of the phenytoin testing market is increasing in incidences of Phenytoin toxicity, reasoning to the increasing burden of epilepsy and post-surgical complication causing seizures.
According to the data from statistics released by Agency for Healthcare Research and Quality (AHRQ) the prescription rate for phenytoin in 2016 totaled more than 2.75 Mn prescription in US alone.
The increasing prescription rate is anticipated to propel the demand for phenytoin testing fueled by efficacy testing and standard dose control measures. The development in Phenytoin specific reagents and advanced ELISA test are anticipated to drive the growth of the sales of the phenytoin testing.
Subsequently, growing services penetration from key service providers is anticipated to fuel the growth of the demand for phenytoin testing market. For instance, the growing services in Phenytoin Test from leading diagnostic company, ARUP Laboratories is targeting the product on rapid testing of phenytoin toxicity, which is expected to offer the service provider an edge in phenytoin testing market.
However, irregularity in test results and additional cost burden is anticipated to impede the growth of the phenytoin testing market.
The Phenytoin Testing offers primeval advantage in preventing renal failure and nervous damage. Thereby offering new growth opportunities for the phenytoin testing market. The test service providers in the Phenytoin Testing market are highly focused on reducing the time required in obtaining results.
The global phenytoin testing market is segmented into the following regions - North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa.
North America is a prominent regional market for Phenytoin Testing due to high prescription rate, wide range of pathological test availability and developed health care infrastructure in the region.
In East Asia, China is prominent phenytoin testing market due to widespread adoption of phenytoin testing additionally higher incidence of epilepsy.
Latin America phenytoin testing market is anticipated to shoe sluggish growth rate owing to low adoption rate for Phenytoin toxicity testing.
South Asia is anticipated to exhibit a higher growth rate due to higher renal failure rate in epileptic patients around the region.
Growth in the Middle East and Africa is stagnant and slow growth in the healthcare standards in the region.
The key players of the phenytoin testing market are focusing on enhancing and adopting strategies like enhancing the durability, sizes and its use to thrive business. This is driving down the sales of phenytoin testing.
Some of the key participating players indulged in the sales of phenytoin testing are:
These market players are anticipated to drive the phenytoin testing market by introducing new products and expanding geographically.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
| Report Attribute | Details |
| Growth Rate | CAGR of 1.4% from 2022 to 2032 |
| Base year for estimation | 2022 |
| Historical data | 2015 – 2021 |
| Forecast period | 2023 – 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Product Type, End User, & Region |
| Regional scope | North America, Latin America, Europe, East Asia, South Asia, Oceania, The Middle East & Africa |
| Country scope | U.S., Canada, Mexico, Brazil, Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Russia, Poland, Japan, China, India, South Korea, ASEAN, Australia & New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
| Key companies profiled | Roche Molecular Systems Inc, Abbott Diagnostics, ARUP Laboratories, Quest Diagnostics, Lybrate Inc, Denka Seiken co. Ltd., and Portea Medical |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The phenytoin testing market grows at a rate of 1.4% CAGR during the forecast period 2022 to 2032.
Key players holding a substantial phenytoin testing market share include Roche Molecular Systems Inc, Abbott Diagnostics, ARUP Laboratories, Quest Diagnostics, Lybrate Inc, denka seiken co. Ltd., and Portea Medical.
Demand for phenytoin testing is likely to rise on the back of increased toxicity check is also projected to contribute to the growth of the phenytoin testing market share.
Explore Similar Insights
Phenytoin Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
